Extracellular NM23 Protein as a Therapeutic Target for Hematologic Malignancies
An elevated serum level of NM23-H1 protein is a poor prognostic factor in patients with various hematologic malignancies. The extracellular NM23-H1 protein promotes the in vitro growth and survival of acute myelogenous leukemia (AML) cells and inversely inhibits the in vitro survival of normal perip...
Saved in:
Main Authors: | Junko Okabe-Kado, Takashi Kasukabe, Yasuhiko Kaneko |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Advances in Hematology |
Online Access: | http://dx.doi.org/10.1155/2012/879368 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gab Adapter Proteins as Therapeutic Targets for Hematologic Disease
by: Sheetal Verma, et al.
Published: (2012-01-01) -
Extracellular Vesicles: A New Prospective in Crosstalk between Microenvironment and Stem Cells in Hematological Malignancies
by: Ilaria Laurenzana, et al.
Published: (2018-01-01) -
Oncolytic Virotherapy for Hematological Malignancies
by: Swarna Bais, et al.
Published: (2012-01-01) -
Decitabine Induced Delayed Cardiomyopathy in Hematologic Malignancy
by: Pradyumna Agasthi, et al.
Published: (2018-01-01) -
Extracellular Cold-Inducible RNA-Binding Protein and Hemorrhagic Shock: Mechanisms and Therapeutics
by: Naureen Rashid, et al.
Published: (2024-12-01)